Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies

被引:34
作者
Kang, IS [1 ]
Siperstein, R [1 ]
Quan, T [1 ]
Breitenstein, ML [1 ]
机构
[1] Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06520 USA
关键词
anti-dsDNA antibodies; anti-extractable nuclear antigen (ENA) antibodies; anti-nuclear antibodies (ANAs); connective tissue disease; indirect immunofluorescence assay;
D O I
10.1007/s10067-004-0937-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monovariate and multivariate analyses including logistic regression were performed to determine associations among predicting variables [ age, gender, immunofluorescence pattern, and anti-nuclear antibody ( ANA) titer] and anti-extractable nuclear antigen (ENA) and - dsDNA antibodies (Abs) in 1089 patients with positive fluorescent ANA (FANA) test results. Samples with high titer ANAs had an increased frequency of anti-ENA and - dsDNA Abs. The receiver operating (ROC) curves of the ANA titer for anti-ENA Abs had a larger under the curve area compared to the ROC curve for anti-dsDNA Abs, indicating that ANA titer is better for predicting anti-ENA Abs than anti-dsDNA Abs. There was no relation noticed between immunofluorescence patterns and anti-ENA and - dsDNA Abs except an increased frequency of anti-dsDNA Abs found in samples with a homogeneous pattern. Probability calculations on the basis of the ANA pattern and the titer showed that samples with low titer ANAs ( 1: 160 or less) had low probabilities for anti-ENA Abs (0.002 - 0.009) regardless of immunofluorescence patterns. However, samples with a homogeneous pattern at any titers including low titers had high probabilities for anti-dsDNA Abs. A decreased frequency of anti-dsDNA Abs as measured by Crithidia assay was noticed in samples from patients aged 50 or older. In contrast, no association was noticed between age and anti-ENA Abs. There was no female preponderance found in the presence of anti-ENA and - dsDNA Abs. In conclusion, our study shows that the ANA titer but not the immunofluorescence pattern is useful in predicting anti-ENA Abs. In contrast, both the ANA titer and the immunofluorescence pattern help in predicting anti-dsDNA Abs. Samples with low titer ANAs 1: 160 or less) may not need a further test for anti-ENA Abs unless an ANA-associated disease is highly suspected. However, a test for anti-dsDNA Abs should be considered in samples with a homogeneous pattern at any titer including low titers.
引用
收藏
页码:509 / 515
页数:7
相关论文
共 9 条
[1]  
[Anonymous], 1997, Text book ofRheumatology
[2]  
Brown B.W., 1980, Biostatistics Casebook
[3]  
Craig WY, 1999, J RHEUMATOL, V26, P914
[4]  
DEVLAM K, 1993, CLIN EXP RHEUMATOL, V11, P393
[5]   CASCADE TESTING FOR AUTOANTIBODIES IN CONNECTIVE-TISSUE DISEASES [J].
HOMBURGER, HA .
MAYO CLINIC PROCEEDINGS, 1995, 70 (02) :183-184
[6]  
Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71
[7]   Usefulness of antinuclear antibody testing to screen for rheumatic diseases [J].
Malleson, PN ;
Sailer, M ;
Mackinnon, MJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (04) :299-304
[8]   Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing [J].
Peene, I ;
Meheus, L ;
Veys, EM ;
De Keyser, F .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (12) :1131-1136
[9]  
Vaile JH, 2000, CLIN EXP RHEUMATOL, V18, P433